Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.

Clémence PinardMarc DebledHouda Ben RejebValérie VelascoChristine Tunon de LaraStéphanie HoppeElodie RichardVéronique BrousteHervé BonnefoiGaëtan Marie MacGrogan

Published in: Breast cancer research and treatment (2019)

These results suggest that the combination of pathological (RCB index) and tumor micro-environmental features (CD4 + TILs) help refining the prognosis of TNBC patients with RD following NAC.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
papillary thyroid
sentinel lymph node
transcription factor
squamous cell
rectal cancer
peripheral blood
risk factors
radiation therapy
early stage
risk assessment
genome wide analysis